Two Sigma Advisers’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Two Sigma Advisers’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-254,100	Closed	-$11M	–	2127
2015 Q3	$11M	Sell	254,100 -300	-0.1%	-$12.7K	0.07%	316
2015 Q2	$10.8M	Buy	254,400 +8,200	+3%	+$346K	0.08%	283
2015 Q1	$9.55M	Buy	246,200 +26,400	+12%	+$1.02M	0.07%	320
2014 Q4	$7.4M	Sell	219,800 -51,600	-19%	-$1.82M	0.06%	372
2014 Q3	$9.5M	Buy	271,400 +49,500	+22%	+$1.7M	0.07%	310
2014 Q2	$7.29M	Buy	221,900 +50,400	+29%	+$1.72M	0.06%	366
2014 Q1	$6.32M	Sell	171,500 -8,100	-5%	-$297K	0.06%	366
2013 Q4	$6.89M	Buy	179,600 +13,300	+8%	+$420K	0.07%	304
2013 Q3	$4.56M	Sell	166,300 -28,698	-15%	-$680K	0.05%	354
2013 Q2	$4.1M	Buy	+194,998	New	+$3.81M	0.06%	294

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Two Sigma Advisers's WX Position: Q4 2015 in Review

Two Sigma Advisers sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 254,100 shares — an estimated $11M sold.

Two Sigma Advisers first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $11M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Two Sigma Advisers reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Two Sigma Advisers sold 254,100 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $11M.
Two Sigma Advisers first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Two Sigma Advisers's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $11M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Two Sigma Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.